Cancer cell lines are extremely valuable tools for carcinoma research. Biodiversity of cell lines and continuous random mutation in cell lines during passage, however, might result in phenotypic inconsistency and lead to biased experimental conclusions. Using statistics based on known and inferred protein interaction networks, as well as public research literature database, our study shows that essential driver genotypes of cell lines might have hidden impact on research results. Furthermore, by comprehensive genomic profiling of 8 most common used urothelial cell lines and comparing them to previous publications, we found that regardless of similar short tandem repeat (STR) profile, driver gene loss in cell lines could happen by random mutation. Our results suggest that clinical research using urothelial carcinoma cell lines might be influenced by cell line genotypes which could only be determined by next-generation sequencing. Meanwhile, this study indicates that the conditionally reprogrammed cells (CRCs), which closely resemble original tumor tissue, might represent a better alternative for in vitro research, which may be better used for personalized medicine.
Preexisting genetic mutations in cells might influence phenotypes caused by other molecular biology manipulations. For instance, the bladder cancer (BCa) cell RT4 harbors a TACC3-FGFR3 fusion but not TP53 mutation ( Fig. 1F ), while the other BCa cell T24 have TP53 mutation but not FGFR3 mutation [1] . To study whether these preexisting genotype could influence research conclusions, we performed a systematic review of the literature for urothelial carcinoma-related 1,589 articles either used or not used RT4 (Table S1 ). Firstly, we found significant association between the pathway which the target gene belongs and RT4 usage frequency: if the gene was known to associate with TP53 pathways, the research was less likely to include RT4 (Fig. 1A-B and Table S2 ).
Then, we calculate the frequency of using RT4 and/or T24 for research on particular target gene (Table S3 ). Using PPI networks [2] , we calculated the "interaction distance" between these gene to TP53 and FGFR3. Again, RT4 usage frequency is increased in research of genes with closer relationship to FGFR3 compared to TP53 (Fig. 1C ). These results suggested the existence of latent bias in research: researcher might implicitly select consistent results by selecting carcinoma cell lines. The preexisting carcinoma cell line mutation landscape could determine its response to particular molecular biology manipulation, such response could be inconsistent. However, only consistent results would be reported.
Moreover, since genotype determined phenotype, identifying the genotype of carcinoma cell line is critical to the research result. State-of-the-art practices require genotyping cell lines using short tandem repeat (STR) [3] . However, STR only identifies whether cell lines are cross-contaminated, but does not fully report the genomic changes of cell lines. We collected 8 most widely used BCa cell lines and confirmed their identity by STR. Whole-exome sequencing (WES) of the 8 cell lines together with 2 conditionally reprogrammed cells (CRCs) [4] and 2 BCa tissues (Table S4 ) showed the CRCs have good consistency with tumor tissues, however, the cell lines showed significant deviation from genuine BCa by wide-the previous reports [5] , we detected only a tiny fraction of the known driver FGFR3 fusion in SW780 ( Fig. 1E ). These results indicated although the carcinoma cell lines were not contaminated, they undergone pervasive genetic drift characterized by copy number variation and random loss of driver mutation.
Together, carcinoma cell line genotypes could influence research results by modifying molecular manipulation outcomes. Such influences could be implicit or explicit, and represents researcher's selection bias in research. Furthermore, the genotypes undergone neutral genetic drift, which might lead to loss of important driver mutation and gain of novel genetic identity. Hence, our opioion suggests WES, instead of STR, should be widely used for determining carcinoma cell line genotype in future research. Meanwhile, the CRCs, a leading technology for living biobank, which closely resembles original tumor tissue, might represent a better alternative for in vitro research, which may be the direction of future precise medicine. OR "bladder tumor" [TIAB])". Publication date was not restricted in our search. Reference lists of the included studies and supplemental materials were checked manually to further identify related studies. Three reviewers independently screened the title, abstract and keywords of each article retrieved. Full-text papers were screened for further assessment if the information given suggested that the study fulfilled the inclusion criteria and did not meet the exclusion criteria. Discrepancies were settled by discussion and consensus with all the authors.
Methods

Literature search strategy and selection of studies
DNA extraction and NGS library preparation
Genomic DNA is extracted from cultured cells using Qiagen tissue DNA column. We 
Cell culture
All urothelial cell lines were purchased from Cell Bank of the Chinese Academy of Sciences.
The cell lines are authenticated via short tandem repeat (STR) analysis. The medium and culture conditions are as follows: 
Cell line
Bioinformatic pre-processing and determination of somatic mutation events
For SNV/indel and CNV calls, reads were trimmed using cutadapt to remove poly-T-tails, adaptors and the first 10bp from each end before being mapped to GRCh37+decoy reference genome using bwa-mem. For structural variation calls, reads were only trimmed to remove adaptors before mapping. Before calling any variants, the bam files were duplication-marked, Haplotypecaller callset into sequenza and CNVkit, to estimate correct copy number information for each segment. Structural variation was called and annotated using the iCallSV pipeline. Mavis (using Lumpy) was also used to search for possible low-frequency SV. MSI score is calculated with MSIsensor. To calculate mutation signature, the filtered, passed, main-and subclonal mutations were passed to deconstructSig.
Quality control of sequenced samples
Quality control of the files was done with in-house script. We checked the mapping quality, mapping rate, duplication rate and uniformity to control for molecular assay and sequencing.
Tumor samples in this study were sequenced to a median of > 200x. 
